Origen de la red de primer grado Kendra Sweeney.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 8 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Kendra Sweeney a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| NEXPRISE, INC. | Miscellaneous Commercial Services | Director/Board Member | |
| IGNYTA INC | Biotechnology | Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
| REALM THERAPEUTICS PLC | Pharmaceuticals: Major | Director of Finance/CFO | |
| Lehigh University | College/University | Undergraduate Degree | |
Thorell Consulting
 Thorell Consulting Miscellaneous Commercial ServicesCommercial Services Thorell Consulting provides business consulting services. The private company is based in New York. | Miscellaneous Commercial Services | President | |
| ESSA PHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
Palladio Biosciences, Inc.
 Palladio Biosciences, Inc. BiotechnologyHealth Technology Palladio Biosciences, Inc. develops transformative medicines for orphan diseases. Its pipeline includes Lixivaptan, a selective vasopressin V2 receptor antagonist for the treatment of polycystic kidney disease, a life-threatening genetic disease. The company was founded by Lorenzo Pellegrini in 2015 and is headquartered in Newtown, PA. | Biotechnology | Director of Finance/CFO | |
ApcinteX Ltd.
 ApcinteX Ltd. BiotechnologyHealth Technology ApcinteX Ltd. develops and markets anticoagulant APC pathway to treat haemophilia. The company is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
| CENTESSA PHARMACEUTICALS PLC | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
| Living Beyond Breast Cancer | Director/Board Member | ||
Z Factor Ltd.
 Z Factor Ltd. BiotechnologyHealth Technology Z Factor Ltd. operates as a drug discovery company. It identifies and develops therapeutic agents to treat alpha-1-antitrypsin deficiency. The company was founded by James Huntington in 2015 and is headquartered in Babraham, the united Kingdom. | Biotechnology | Director/Board Member | |
Capella Bioscience Ltd.
 Capella Bioscience Ltd. Pharmaceuticals: MajorHealth Technology Capella Bioscience Ltd. develops medicines based on monoclonal antibodies to the next generation therapeutic targets in oncology and autoimmune disease. The company was founded by Steve Holmes in 2014 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| SERES THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
| Instituto de Empresa SL | College/University | Masters Business Admin | |
| BICYCLE THERAPEUTICS PLC | Biotechnology | Director/Board Member | |
| Marche Polytechnic University | College/University | Undergraduate Degree | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Roche Diagnostics Corp.
 Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN. | Medical Specialties | Corporate Officer/Principal | |
AstraZéneca Farmacéutica Spain SA
 AstraZéneca Farmacéutica Spain SA Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZéneca Farmacéutica Spain SA is a Spanish pharmaceutical company that produces pharmaceutical products. The company is based in Madrid, Spain. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Boston University | College/University | Masters Business Admin | |
| Bentley University | College/University | Graduate Degree | |
| University of Glasgow | College/University | Corporate Officer/Principal | |
| European League Against Rheumatism | Corporate Officer/Principal | ||
| The University of North Carolina at Chapel Hill | College/University | Undergraduate Degree | |
| UNC School of Law | College/University | Graduate Degree | |
Softbank Group International
 Softbank Group International Specialty TelecommunicationsCommunications Part of SoftBank Group Corp., Softbank Group International provides mobile communication, broadband and telecom services. The company is based in San Carlos, CA. The CEO of the company is Alex Bernard Clavel. | Specialty Telecommunications | Corporate Officer/Principal | |
W.K. Kellogg Foundation
 W.K. Kellogg Foundation Investment Trusts/Mutual FundsMiscellaneous W.K. Kellogg Foundation supports children in the areas of education, health, secure families, racial equity and civic engagement. The foundation was founded in 1930 by W.K. Kellogg and is headquartered in Battle Creek, MI. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Hangar
 Hangar Investment ManagersFinance Hangar (Hangar) is a private equity/ venture capital firm founded in 2014. The firm is headquartered in New York. | Investment Managers | Consultant / Advisor | |
| U.S. House of Representatives | General Government | Corporate Officer/Principal | |
| ABBVIE INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| DANAHER CORPORATION | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| ANACOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Founder | |
Genetrix, Inc.
 Genetrix, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sanofi, Genetrix, Inc. is a genetics testing research company. The company is based in Scottsdale, AZ. Genetrix was acquired by Genzyme Corp., part of Sanofi from April 08, 2011 on May 06, 1996 for $39.20 million. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| The University of Tulsa | College/University | Undergraduate Degree | |
Infectious Disease Research Institute
 Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Director/Board Member | |
Indigo Ag, Inc.
 Indigo Ag, Inc. BiotechnologyHealth Technology Indigo Ag, Inc. provides microbial solutions. The company was founded by Noubar Afeyan, David A. Berry, and Geoffrey von Maltzahn in 2013 and is headquartered in Charlestown, MA. | Biotechnology | Chief Executive Officer | |
| Harvard Business School | College/University | Masters Business Admin | |
| A.P. Giannini Foundation | Director/Board Member | ||
| SMALL BUSINESS DEVELOPMENT GROUP, INC. | Financial Conglomerates | Corporate Officer/Principal | |
Better Therapeutics LLC
 Better Therapeutics LLC Medical SpecialtiesHealth Technology Part of Better Therapeutics, Inc., Better Therapeutics LLC is a company that focuses on clinical development and creating habits that heal to reduce the need for other treatments. The company is based in San Francisco, CA. The company is pioneers in the field of prescription digital therapeutics for treating a range of cardiometabolic diseases. The company was founded by David P. Perry and Kevin J. Appelbaum. Kevin J. Appelbaum has been the CEO of the company since 2015. Better Therapeutics was acquired by Mountain Crest Acquisition Corp. II on October 28, 2021 for $164.55 million. | Medical Specialties | Founder | |
| BETTER THERAPEUTICS, INC. | Medical Specialties | Founder | |
| CIRCOR INTERNATIONAL, INC. | Industrial Machinery | Comptroller/Controller/Auditor | |
| University of Massachusetts | College/University | Undergraduate Degree | |
| BRUKER CORPORATION | Medical Specialties | Corporate Officer/Principal |
Estadísticas
Internacional
| Estados Unidos | 38 |
| Reino Unido | 8 |
| España | 3 |
| Suiza | 3 |
| Canadá | 2 |
Sectorial
| Health Technology | 24 |
| Consumer Services | 13 |
| Commercial Services | 5 |
| Finance | 3 |
| Communications | 2 |
Operativa
| Director/Board Member | 23 |
| Corporate Officer/Principal | 22 |
| Chief Executive Officer | 8 |
| President | 7 |
| Undergraduate Degree | 7 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Jose-Carlos Gutiérrez-Ramos | 24 |
| David Perry | 13 |
| Ann Thorell | 13 |
| Tonya Williams | 9 |
| Luca Scavo | 7 |
| Stephen J. Carriere | 4 |
| Xiaoli Liu | 3 |
| Iain Mcinnes | 3 |
- Bolsa de valores
- Insiders
- Kendra Sweeney
- Conexiones Empresas
